KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Resmed (RMD) Tax Provisions (2016 - 2025)

Resmed's Tax Provisions history spans 17 years, with the latest figure at $103.6 million for Q4 2025.

  • For Q4 2025, Tax Provisions rose 40.51% year-over-year to $103.6 million; the TTM value through Dec 2025 reached $332.8 million, up 16.26%, while the annual FY2025 figure was $276.8 million, 13.53% up from the prior year.
  • Tax Provisions reached $103.6 million in Q4 2025 per RMD's latest filing, up from $98.3 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $296.5 million in Q1 2021 to a low of $35.5 million in Q4 2021.
  • Average Tax Provisions over 5 years is $72.4 million, with a median of $54.0 million recorded in 2021.
  • Peak YoY movement for Tax Provisions: skyrocketed 939.65% in 2021, then plummeted 84.04% in 2022.
  • A 5-year view of Tax Provisions shows it stood at $35.5 million in 2021, then skyrocketed by 37.26% to $48.8 million in 2022, then rose by 3.85% to $50.7 million in 2023, then surged by 45.5% to $73.7 million in 2024, then skyrocketed by 40.51% to $103.6 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Tax Provisions are $103.6 million (Q4 2025), $98.3 million (Q3 2025), and $78.3 million (Q2 2025).